SME Times is powered by   
Search News
Just in:   • EU leaders need to relook at GSP+ trade status for Pakistan  • NHAI likely to garner Rs 35,000-40,000 crore from road assets in FY26  • 30 lakh join PM Vishwakarma Scheme in 2 years, 4.7 lakh loans worth Rs 41,188 crore approved  • India-US trade talks resume amid renewed hopes over tariffs  • Passenger vehicle sales down in Aug as consumers await GST cuts, 2-wheeler sales up: SIAM 
Last updated: 25 Feb, 2021  

Vaccine.Thmb.jpg S.Korea ready for vaccine roll out as shipment begins for doses

Vaccine.jpg
   Top Stories
» 30 lakh join PM Vishwakarma Scheme in 2 years, 4.7 lakh loans worth Rs 41,188 crore approved
» India-US trade talks resume amid renewed hopes over tariffs
» Passenger vehicle sales down in Aug as consumers await GST cuts, 2-wheeler sales up: SIAM
» Nifty, Sensex open flat as investors wait for fresh cues, US Fed meet outcome
» India’s GDP growth to remain steady at 6.5 pc, another RBI rate cut likely this fiscal
IANS | 25 Feb, 2021
South Korea has set the ball rolling for the nationwide Covid vaccination roll out as the first batch of about 1.5 million vaccine doses headed to the country, which is nearing 90,000 cases since the outbreak of the pandemic in January last year.

The nationwide distribution of the AstraZeneca vaccine for some 750,000 people, mostly health care workers and patients at nursing homes, came as the country is set to kick off the free inoculation campaign on Friday, Yonhap reported.

The vaccine doses were produced at a local plant by SK Bioscience Co. under a manufacturing partnership deal with British-Swedish pharmaceutical giant AstraZeneca.

The sealed one-ton truck, escorted by the police and military vehicles and personnel, first left a cold chain logistics warehouse in Icheon, 80 kilometers southeast of Seoul, around 5:50 a.m. (local time).

The first shipment for a total of 55 container trucks was delayed for around two hours at the site due to extra caution about maintaining storage temperatures, health authorities said.

A total of 1.57 million doses of vaccines under AstraZeneca's full two-dose regimen will be delivered to a total of 1,900 long-term care hospitals and public health centers across the country for the next five days.

The first batch of AstraZeneca's vaccine is enough to provide jabs to 785,000 people, which is 35,000 higher than the previous estimate.

The AstraZeneca vaccine is deemed more convenient for mass inoculations as its storage temperature is 2 to 8 C, compared with the vaccine by US pharmaceutical giant Pfizer Inc. that requires ultra-cold chain storage.

According to health authorities, a total of 289,271 people, or 93.6 per cent of the patients and people working at facilities including sanatoriums, nursing facilities and rehabilitation facilities will receive the first shot.

Meanwhile, Pfizer's vaccine will be offered to medical staff members starting Saturday. South Korea hopes to attain herd immunity by November after inoculating 70 percent of its population by September.

On Thursday, the country reported 396 more virus cases, raising the total caseload to 88,516. Thursday's daily caseload marks a slight drop from 440 posted the previous day. The figures hovered above 600 last week before falling below 500 over the weekend and under 400 earlier this week on fewer tests.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹84.00
₹82.25
UK Pound
₹104.65
₹108.10
Euro
₹92.50
₹89.35
Japanese Yen ₹56.10 ₹54.40
As on 25 Jul, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter